The CDFI Fund Transparency Act (S 2704) requires the Treasury Secretary (or their designee) to annually testify before the Senate Banking Committee and House Financial Services Committee about the Community Development Financial Institutions (CDFI) Fund's operations. This testimony would cover the previous fiscal year's activities, at the committees' discretion. The bill directly affects the Treasury Department and the CDFI Fund, aiming to increase transparency in how the fund operates. It does not change funding or program rules, only adding a reporting requirement for the Treasury.
The Telehealth Modernization Act extends Medicare telehealth flexibilities through 2027, allowing more patients to access care remotely without geographic restrictions. It expands who can provide telehealth services (including audio-only visits), extends telehealth use for hospice recertification, and updates coverage for in-home cardiopulmonary rehabilitation. The bill also extends "acute hospital care at home" program flexibilities through 2030 and requires a study on this program's effectiveness. Additionally, it includes provisions to improve telehealth access for patients with limited English proficiency and enhances Medicare coverage for virtual diabetes prevention programs. These changes primarily affect Medicare beneficiaries, healthcare providers, and telehealth service companies.
This bill creates federal grants to help community and municipal utilities repair or replace aging natural gas pipelines. It directly affects publicly owned gas systems by funding projects to reduce leaks, improve safety, and prepare for alternative energy transport. Grants can cover pipeline repairs, equipment purchases, and must prioritize job creation and benefits for disadvantaged communities. The bill authorizes $200 million annually (2026-2029) from general revenues, with limits on funding per utility and strict requirements for civil rights and environmental compliance.
This bill requires hospitals with approved medical residency programs to publicly report data on applicants and acceptances from both osteopathic (D.O.) and allopathic (M.D.) medical schools. Specifically, hospitals must submit annual data showing the number of applicants and accepted candidates from each school type, along with a written affirmation that they consider both equally and accept scores from either the COMLEX or USMLE exams. The data must be published online by the Health and Human Services Secretary starting in 2025. Hospitals failing to submit this information face a 2% annual reduction in Medicare payments beginning in 2026. The bill explicitly states it does not mandate specific acceptance rates or federalize medical education.
This bill requires most health insurance plans to cover HIV prevention services - including PrEP and PEP drugs, related lab tests, counseling, and monitoring - without cost-sharing (like copays or deductibles) or prior approval. It applies to private insurance, Medicare, Medicaid/CHIP, and federal employee health plans, directly affecting people who use HIV prevention medications. Key provisions mandate 100% coverage for FDA-approved HIV prevention drugs, eliminate cost-sharing for these services, and prohibit insurers from requiring preauthorization for them. The bill defines covered services to include all necessary components of HIV prevention care as outlined in current public health guidelines.
HR 5126, the HIV Prevention Now Act, appropriates $2.165 billion for the CDC's National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention for fiscal year 2026. This funding is in addition to existing CDC appropriations and must be used exclusively by that specific center for its programs, with no transfer to other entities. The bill directly affects the CDC's public health operations by providing dedicated resources for prevention and treatment programs targeting HIV, viral hepatitis, STDs, and tuberculosis. It does not create new policies or alter eligibility but ensures sustained funding for existing prevention efforts at the federal level.
This bill requires the Bureau of Prisons (BOP) to issue photo identification cards meeting REAL ID standards to U.S. citizen prisoners being released from federal custody within 180 days of enactment. The card is valid for 18 months and must be accepted by states for state ID purposes (through negotiated agreements) and by federal programs like Social Security, Medicare, Medicaid, food assistance, and housing programs. It directly affects federal prisoners upon release, states (through required negotiations), and federal agencies that provide services requiring ID. The law mandates annual reports to Congress on state agreement progress but does not change existing prerelease planning procedures.
HR 5156, the COUNT Act, requires federal agencies to share specific immigration and demographic data with the Department of Commerce to improve national citizenship statistics. It mandates agencies like DHS, SSA, and HHS to provide access to records including immigration files, passport applications, and Medicaid data, while directing the Census Bureau to add a citizenship question to the 2030 census and American Community Survey. The bill also directs the Commerce Department to seek state administrative records for citizenship data and requires annual reports to Congress on state cooperation. This directly affects federal and state agencies by altering data-sharing protocols for immigration and citizenship tracking.
HR 5133, the Patients’ Right to Know Their Medication Act of 2025, requires drug manufacturers to provide standardized printed patient medication information (PMI) with each prescription dispensed in non-hospital settings. This PMI must include clear, plain-language details on drug name, usage instructions, warnings, side effects, storage, disposal, and interactions - formatted consistently with readable text and graphics. The bill directly affects patients receiving prescriptions, ensuring they get accessible, non-promotional printed information to improve safety and reduce errors. The FDA would establish regulations within one year of enactment, mandating that manufacturers include this standardized PMI on prescription drug packaging.
HR 5142, the Home Health Stabilization Act of 2025, prevents payment cuts to Medicare home health providers for 2026 and 2027. It requires the Medicare Secretary to adjust payment rates to fully offset two planned negative adjustments (-4.059% and -5.0%) that would have reduced payments under the 2026 rate update rule. This ensures home health agencies receive full reimbursement for services during those years without further reductions based on prior payment formulas. The bill directly affects home health providers who rely on Medicare payments for patient care.
HRES 675 is a symbolic resolution expressing the U.S. House of Representatives' support for designating September 2025 as "National Prostate Cancer Awareness Month." It directly affects all Americans, particularly men at risk of prostate cancer - including those with family history, African-American men (who face higher incidence and mortality rates), and men under 65 (40% of new cases). The resolution calls for raising public awareness about screening methods, encouraging research into prevention and treatment, and promoting community actions to combat prostate cancer. It does not create new laws or allocate funding, but urges public and private efforts to improve early detection and outcomes.
This resolution (HRES 674) formally condemns Representative Rashida Tlaib for attending the People’s Conference for Palestine, alleging she promoted terrorism and antisemitism there. The resolution cites specific speakers at the event who called for disrupting U.S. military supply chains, praised the October 7 Hamas attacks as "natural," advocated assassinating politicians, and honored terrorists. It claims Tlaib’s participation and rhetoric - such as labeling support for Israel as "sellout" - violated House standards by promoting extremism. The bill seeks a formal censure, a non-binding disciplinary action by the House. This is a procedural resolution addressing conduct, not creating new law.
